A new generative AI tool can create those studies in minutes.
That directive informed Atropos' development of ChatRWD, which Atropos Health launched in beta form in October to 75 customers.
Atropos says it's the first generative AI tool to create publication-grade studies from clinical data in minutes.
AdvertisementAtropos' $33 million Series B funding follows Atropos' $14 million Series A in August 2022, bringing the company's total funding to $54 million.
See the 22-slide pitch deck Atropos Health used to raise $33 million in Series B funding.
Persons:
—, Brigham Hyde, Valtruis, Jim Breyer's Breyer, Laurene Powell Jobs, Nigam Shah, Saurabh, Hyde, Atropos, Green Button, Green, Johnson, Johnson's Janssen
Organizations:
Service, Business, Atropos, Cencora Ventures, McKesson Ventures, Merck GHI Fund, Presidio Ventures, Stanford University, National Institutes of Health, Atropos Health, pharma
Locations:
Geneva, Arcadia